Biotechnology Stockmarket Biotech

Biotech Stock in Focus: Medivation-Astellas’ Xtandi’s Label Expanded

Medivation, Inc (MDVN) and partner Astellas Pharma Inc (ALPMY) received a major boost with the FDA expanding the label of their prostate cancer treatment, Xtandi. Xtandi, which was earlier approved for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC) who had previously received docetaxel (chemotherapy), can now be used in patients with metastatic…

Read More

Stock in News: A Look At Microsoft (NASDAQ MSFT) Keyboard

Microsoft Corporation (NASDAQ MSFT) is branching out by creating universal products. The company just introduced a universal mobile keyboard which will work with many different products including iPad, iPhone, Android products, and Windows tablets. The keyboard will launch in October with the estimated retail price of $79.95. Microsoft recently introduced a universal keyboard that works…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓